Volume 2 of our Industry Updates sees the second Covid-19 wave still raging and highlights the latest vaccine developments.
Pandemic Stats Update
Second COVID-19 Wave Still Raging
Pfizer/BioNTech Vaccine Rollout/Allergic Reactions
Astra Zeneca/Sputnik Discussions
CSL/University of Queensland’s Protein Sub-Unit Based Vaccine Cancelled
Johnson & Johnson (J&J) One-Shot Adenovirus Vaccine Now up to 45,000 Stage 3 Trial Participants
Valneva Whole Inactivated Virus (WIV) Vaccine Enters Trials
Novavax Executives Sell Shares
Gates Provides Funding for Second Wave Covid-19 Vaccines
Welcome to our first Industry Update, which brings you the latest news in Covid-19 Vaccine Developments and Industry Financial Updates.
Covid-19 Vaccine Developments
Industry Financial Valuation Updates